Evidence map›Paper›PMID 33037178›Full record

ArticleTranslational psychiatry2020

Modulation of cognition and neuronal plasticity in gain- and loss-of-function mouse models of the schizophrenia risk gene Tcf4.

D M Badowska, M M Brzózka, N Kannaiyan, C Thomas, P Dibaj, A Chowdhury, H Steffens, C W Turck, P Falkai, A Schmitt and 7 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

D M Badowska *Ludwig Maximillian's University, Department of Psychiatry, Laboratory of Molecular Neurobiology, Munich, Germany.ORCID http://orcid.org/0000-0001-6234-582X
M M Brzózka *Ludwig Maximillian's University, Department of Psychiatry, Laboratory of Molecular Neurobiology, Munich, Germany.ORCID http://orcid.org/0000-0001-8633-2855
N KannaiyanLudwig Maximillian's University, Department of Psychiatry, Laboratory of Molecular Neurobiology, Munich, Germany.ORCID http://orcid.org/0000-0002-7408-6842
C ThomasMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany.ORCID http://orcid.org/0000-0002-7386-1181
P DibajMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany.
A ChowdhuryMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany.
H SteffensMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany.
C W TurckMax Planck Institute of Psychiatry, Proteomics Unit, Munich, Germany.
P FalkaiLudwig Maximillian's University, Department of Psychiatry, Laboratory of Molecular Neurobiology, Munich, Germany.
A SchmittLudwig Maximillian's University, Department of Psychiatry, Laboratory of Molecular Neurobiology, Munich, Germany.
S PapiolLudwig Maximillian's University, Department of Psychiatry, Laboratory of Molecular Neurobiology, Munich, Germany.
V ScheussLudwig Maximillian's University, Department of Psychiatry, Laboratory of Molecular Neurobiology, Munich, Germany.
K I WilligMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany.ORCID http://orcid.org/0000-0002-1860-334X
D Martins-de-SouzaMax Planck Institute of Psychiatry, Proteomics Unit, Munich, Germany.
J S RheeMax Planck Institute of Experimental Medicine, Department of Neurogenetics, Göttingen, Germany.
D MalzahnGeorg-August-University, University Medical Center Göttingen, Department of Genetic Epidemiology, Göttingen, Germany.
M J RossnerLudwig Maximillian's University, Department of Psychiatry, Laboratory of Molecular Neurobiology, Munich, Germany. Moritz.Rossner@med.uni-muenchen.de.ORCID http://orcid.org/0000-0002-0667-3420
Ludwig-Maximilians-Universität München · DEMax Planck Institute of Experimental Medicine · DEMax Planck Institute of Psychiatry · DEStatistisches Bundesamt · DEUniversidade Estadual de Campinas (UNICAMP) · BRUniversitätsmedizin Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transcription factor TCF4 was confirmed in several large genome-wide association studies as one of the most significant schizophrenia (SZ) susceptibility genes. Transgenic mice moderately overexpressing Tcf4 in forebrain (Tcf4tg) display deficits in fear memory and sensorimotor gating. As second hit, we exposed Tcf4tg animals to isolation rearing (IR), chronic social defeat (SD), enriched environment (EE), or handling control (HC) conditions and examined mice with heterozygous deletion of the exon 4 (Tcf4Ex4δ

Indexed as

SchizophreniaAnimalsCognitionDisease Models, AnimalGenome-Wide Association StudyMiceMice, TransgenicNeuronal PlasticityProteomics

Identifiers

PMID33037178
PMCPMC7547694
OpenAlexW3091775680

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.